Two year results from a double-blind, randomized, placebo-controlled study of adefovir dipivoxil (ADV) for presumed precore mutant chronic hepatitis B

被引：9

作者：

Hadziyannis, S

Tassopoulos, N

Heathcote, J

Chang, TT

Kitis, G

Rizetto, M

Marcellin, P

Lim, SG

Chen, SS

Wulfsohn, M

Wollman, M

Fry, J

Brosgart, C

机构：

[1] Henry Durant Hosp, Athens 117548, Greece

[2] Western Attica Hosp, Athens, 94404, Greece

[3] Toronto Western, Toronto, ON, Canada

[4] Georgios Papanikolaou Hosp, Thessaloniki, Greece

[5] Azienda Osped San Giovanni Battista, Turin, Italy

[6] Hop Beaujon, Paris, France

[7] Natl Univ Singapore, Singapore, Singapore

[8] Gilead Sci Inc, Foster City, CA USA

来源：

关键词：

D O I：

10.1016/S0168-8278(03)80758-4

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

492

引用

页码：143 / 143

页数：1